158 related articles for article (PubMed ID: 24666455)
1. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach.
Nadler A; Cukier M; Milot L; Singh S; Law CH
Can J Surg; 2014 Apr; 57(2):E2-8. PubMed ID: 24666455
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
Søndenaa K; Sen J; Heinle F; Fjetland L; Gudlaugsson E; Syversen U
World J Surg; 2004 Sep; 28(9):890-5. PubMed ID: 15593463
[TBL] [Abstract][Full Text] [Related]
3. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
4. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
5. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
6. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679
[TBL] [Abstract][Full Text] [Related]
7. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.
Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT
World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025
[TBL] [Abstract][Full Text] [Related]
8. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
[TBL] [Abstract][Full Text] [Related]
9. The surgical management of neuroendocrine tumour hepatic metastases.
Pathak S; Dash I; Taylor MR; Poston GJ
Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of two-stage hepatectomy for bilobar liver metastases.
Bowers KA; O'Reilly D; Bond-Smith GE; Hutchins RR
Am J Surg; 2012 Jun; 203(6):691-7. PubMed ID: 22154136
[TBL] [Abstract][Full Text] [Related]
12. Treatment of liver metastases in patients with neuroendocrine tumors.
Frilling A; Rogiers X; Malagó M; Liedke OM; Kaun M; Broelsch CE
Langenbecks Arch Surg; 1998 Mar; 383(1):62-70. PubMed ID: 9627173
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for metastatic neuroendocrine tumors.
Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
[TBL] [Abstract][Full Text] [Related]
17. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
18. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection.
Taner T; Atwell TD; Zhang L; Oberg TN; Harmsen WS; Slettedahl SW; Kendrick ML; Nagorney DM; Que FG
HPB (Oxford); 2013 Mar; 15(3):190-5. PubMed ID: 23374359
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases.
Croome KP; Burns JM; G Que F; Nagorney DM
Ann Surg Oncol; 2016 Oct; 23(11):3693-3698. PubMed ID: 27188296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
